Virtual Treatment Zone From Cone Beam CT Commonly Alters Treatment Plan and Identifies Tumor at Risk for Under-Treatment in US or US Fusion-Guided Microwave Ablation of Liver Tumors

• Published in: Technology in cancer research & treatment 2023-01, Vol.22, p.15330338231181284-15330338231181284
• Main Authors: Arrichiello, Antonio, Ierardi, Anna Maria, Caruso, Alessandro, Grillo, Pasquale, Di Meglio, Letizia, Biondetti, Pierpaolo, Iavarone, Massimo, Sangiovanni, Angelo, Angileri, Salvatore Alessio, Floridi, Chiara, Wood, Bradford, Carrafiello, Gianpaolo
• Format: Article
• Language: English
• Subjects: Ablation; Cancer therapies; Catheter Ablation - methods; Computed tomography; Cone-Beam Computed Tomography - methods; Humans; Lesions; Liver; Liver cancer; Liver Neoplasms - diagnostic imaging; Liver Neoplasms - radiotherapy; Liver Neoplasms - surgery; Magnetic resonance imaging; Malignancy; Microwave ablation; Microwaves - therapeutic use; New tools in loco-regional treatments: state of art and future directions; Predictions; Retrospective Studies; Software; Success; Tomography; Treatment Outcome; Tumors
• ISSN: 1533-0346; 1533-0338
• DOI: 10.1177/15330338231181284

Tumor ablation is included in several major cancer therapy guidelines. One technical challenge of percutaneous ablation is targeting and verification of complete treatment, which is prone to operator variabilities and human imperfections and are directly related to successful outcomes, risk for residual unablated tumor and local progression. The use of “Prediction Ablation Volume Software” may help the operating Interventional Radiologist to better plan, deliver, and verify before the ablation, via virtual treatment zones fused to target tumor. Fused and superimposed images provide 3-dimensional information from different timepoints, just when that information is most useful. The aim of this study is to evaluate the technical success and efficacy of an ablation treatment flowchart provided by a cone beam computed tomography (CBCT) “Prediction Ablation Volume Software.” This is a single-center retrospective study. From April 2021 to January 2022, 29 nonconsecutive evaluable patients with 32 lesions underwent liver ablation with Prediction Ablation Volume Software. Each patient was discussed in a multidisciplinary tumor board and underwent an enhanced computed tomography or magnetic resonance imaging approximately 1 month before the procedure, as well as ∼1 month after. Technical success was defined as treatment of the tumor according to the protocol, covered completely by the Prediction Ablation Volume. Technical efficacy was defined as assessment of complete ablation of the target tumor at imaging follow up (∼1 month). Technical success, technical efficacy, and procedural factors were studied. Technical success was achieved in 30 of 32 liver lesions (94%), measuring 20 mm mean maximum diameter. The antenna was repositioned in 16 of 30 (53%) evaluable target lesions. Residual tumor was detected at 1 month imaging follow up in only 4 of 30 (13%) of the treated lesion. Technical efficacy was of 87% in this retrospective description of our process. The implementation of a CBCT Prediction Ablation Volume Software and flowchart for the treatment of liver malignancies altered the procedure, and demonstrated high technical success and efficacy. Such tools are potentially useful for procedural prediction and verification of ablation.